全球止血器械市场：市场规模、份额和趋势分析（2026-2032 年）

2025年全球止血设备市场规模约7.16亿美元。预计到2032年，该市场规模将达到约9.45亿美元，年复合成长率为4.0%。

本报告涵盖止血探针、结扎器械、硬化治疗针和止血粉，这些产品共同构成了完整的全球止血器械市场。报告量化了销售量、平均售价、市场价值、成长率和企业市场占有率。此外，报告还分析了市场趋势和驱动因素、近期併购活动以及技术发展。报告提供了2022年至2024年的历史数据以及至2032年的预测数据。

它反映了医院和内视镜中心如何评估产品性能、联合治疗和设备创新，以改善治疗效果并有效控制消化道出血。

市场概览

止血器械用于控制和预防胃肠道手术过程中的出血。这些器械包括止血探针、血管夹和结扎带、硬化治疗针和止血粉。这些器械对于治疗急性出血、预防术后併发症以及减少手术介入的需求至关重要。

随着患者族群结构和手术趋势的变化，全球市场持续扩张。人口老化以及肝硬化、肝炎和消化性溃疡等疾病盛行率的上升，推动了止血干预措施的需求。消化道出血发生率的增加，促使医疗专业人员采用各种止血解决方案，以提高安全性并缩短手术时间。

影响该市场的最重要发展之一是联合治疗的兴起。研究表明，将硬化针与血管夹或电外科探针相结合的治疗方法成功率高，并能减少再次手术的需求。随着医生和患者都寻求更有效率的治疗方法和更少的復发，这些联合治疗的应用正在增加。

儘管价格压力和采购动态将继续给製造商带来挑战，但手术量的增加、全球市场的扩大以及持续的技术进步预计将维持到 2032 年的长期成长。

市场驱动因素

联合治疗

联合治疗，即硬化针与其他止血器械（如血管夹或电外科探针）联合使用，已被证明比单一器械治疗更有效。这些疗法透过提高止血成功率并减少后续治疗需求，增强了医生的信心并改善了患者的治疗效果。

这种方法不仅提高了临床应用率，也增加了每次手术的设备消费量。随着医院向实证医疗模式转型，对多设备解决方案的偏好将继续推动设备消耗量的成长。

血管夹

随着越来越多医生倾向于使用结扎夹而非结扎来控制出血和闭合的黏膜缺损，结扎夹市场呈现稳定成长的态势。结扎夹通常在每次手术中多次使用，增加了结扎夹的总量。此外，与结扎带相比，结扎夹产品的价格更高，这也推动了市场价值的成长。

夹子设计和展开系统的持续产品创新进一步巩固了这个领域。精确度更高、旋转控制更精准、展开更可靠的设备提高了临床效率和使用者信心。

人口统计因素

人口老化仍然是止血设备市场最强劲的宏观经济驱动因素之一，因为老年人由于慢性肝病、静脉曲张以及其他增加出血风险的合併症，消化道出血的发生率更高。

同时，不良的生活方式，例如饮食不健康、饮酒和非类固醇消炎剂的使用，正在增加消化道出血的发生率，即使在年轻人中也是如此。这些人口统计和行为因素的综合影响预计将使相关手术需求保持高位，并推动市场在2032年之前持续扩张。

提高内视镜能力

内视镜技术的进步使医生无需手术即可治疗多种出血性疾病。现代内视镜系统能够精确显示出血部位，而对电外科能量的更精准控制则有助于更快地凝血。这些优势提高了手术成功率，并促进了止血产品在医院和门诊中心的利用。

市场限制

集团采购组织（GPO）

集团采购组织（GPO）是医院设备的主要采购管道，但同时也限制了市场成长。 GPO汇集需求并协商批量价格，限制了製造商维持较高平均售价的能力。

此外，过度依赖标准化采购协议会限制医院取得新产品或特色产品的机会。严重依赖集团采购组织（GPO）合约的供应商可能会面临价格实现速度较慢以及在签约机构内扩展产品系列的灵活性降低的问题。

替代疗法

药厂持续研发预防意外消化道出血的药物。这些疗法，特别是那些针对抗凝血逆转和溃疡保护的疗法，可能会降低需要手术干预的出血发生率。

这些药物的广泛应用可能会减少手术量，在某些情况下，会减缓对机械和电外科止血设备的需求。

市场竞食

在更广泛的止血市场中，不同设备类型之间的竞争限制了整体价值成长，例如，结扎夹虽然迅速扩张，但市场份额却被电外科探针、热探针和氩等离子体凝固探针蚕食。

这些装置也可与夹子搭配使用，但与硬化疗法针头搭配使用效果最佳。随着产品偏好的变化，某一类别的成长可能会以牺牲其他类别的成长为代价，导致市场内部格局的转变，而非净成长。

目标市场和数据范围

定量范围

市场规模、市占率、市场预测、成长率、销售量、平均售价

定性范围

成长趋势、限制因素、竞争分析及竞争对手SWOT分析、併购、公司概况及产品系列、FDA召回事件、颠覆性技术、影响止血设备需求的疾病概述

时期

基准年为2025年，预测期间为2026-2032年，历史资料为2022-2024年。

数据来源

对内视镜医师、采购经理和行业高管的初步调查、医院采购和监管资料库、进出口资料以及iData Research内部资料库

方法注记

收入预测模型为销售量乘以平均售价，并根据每种设备类型的手术量和使用率假设检验。

目标市场及区隔

• 止血器械市场进一步细分为：

止血探针

结扎装置

硬化治疗针

止血粉

竞争分析

2025年，波士顿科学公司是全球止血器械市场的领导者，在所有主要细分市场中保持着强劲的地位。该公司在血管夹市场的领先地位，得益于2016年推出的Resolution 360™以及2020年Resolution 360™ ULTRA的升级。波士顿科学公司也销售其旗舰止血探针产品线－Gold Probe™系列，该系列产品以其稳定的性能和可靠性而广受认可。

奥林巴斯公司凭藉其丰富的产品系列和在胃肠内视镜领域长期累积的专业技术，位居市场第二。其在结扎器材领域的领先地位也巩固了其竞争优势。此外，奥林巴斯仍是热探针的唯一供应商，其HeatProbes™产品线在全球广泛应用于内视镜热凝治疗。

库克医疗在止血器材市场占有第三大份额。该公司的主打产品是6 Shooter® Universal Saeed®多功能结扎器，该产品广泛应用于内视镜结扎手术。此外，该公司还生产血管夹、电外科探针和硬化治疗针，为多种内视镜应用提供全面的产品组合。

竞争格局集中度适中，前三大企业占了大部分市场份额。区域性参与企业主要服务于对成本较为敏感的市场，定价弹性和本地分销关係是它们的优势所在。

科技与临床趋势

联合治疗方案正逐渐成为治疗消化道出血的标准方法，从而提高了治疗成功率并降低了再次出血的风险。

一次性医疗设备的使用日益普及，尤其是在医院等对感染控制和工作流程效率要求较高的场所。

改进的夹子和探针设计提高了手术精度、旋转控制和放置一致性。

能量型止血技术，如热探针和氩等离子体凝固术，仍是与机械仪器结合使用的重要工具。

随着培训的扩展和指南的製定，医生们对多器械止血技术越来越熟悉。

粉状止血剂作为瀰漫性出血部位和难以触及部位的辅助治疗手段，引起了人们的兴趣。

这些趋势显示市场正在转向兼顾安全性、成本和临床效率的综合手术解决方案。

地区

本期内容涵盖北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。

调查方法附录与简称

目录

图表清单

图表列表

调查方法

全球关税的影响

止血设备市场

• 执行摘要
  • 全球止血器械市场概览
  • 竞争分析
  • 流程分段
  • 市场区隔
  • 目标区域
• 介绍
• 手术次数
• 市场概览
  • 按细分市场
  • 按地区
• 市场分析与预测
  • 止血探针市场
  • 结扎装置市场
  • 硬化疗法针市场
  • 止血粉市场
• 驾驶员和约束装置
• 竞争市占率分析

简称

The global hemostasis device market was valued at approximately $716 million in 2025. The market is projected to grow at a compound annual growth rate (CAGR) of 4.0 percent, reaching nearly $945 million by 2032.

This report covers hemostasis probes, ligation devices, sclerotherapy needles, and hemostasis powders, which together form the complete global hemostasis device market. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers and limiters, recent mergers and acquisitions, and technology trends. The report includes historical data from 2022 to 2024 and forecasts through 2032.

The scope reflects how hospitals and endoscopy centers evaluate product performance, combination therapies, and device innovation to improve outcomes and manage gastrointestinal bleeding effectively.

Market Overview

Hemostasis devices are used during gastrointestinal procedures to control and prevent bleeding. They include hemostasis probes, ligation clips and bands, sclerotherapy needles, and hemostasis powders. Collectively, these devices are essential for treating acute bleeding conditions, preventing post-procedure complications, and reducing the need for surgical intervention.

The global market continues to expand as patient demographics and procedural trends shift. The aging population, coupled with the increasing prevalence of diseases such as cirrhosis, hepatitis, and peptic ulcers, is driving demand for hemostatic interventions. As the incidence of gastrointestinal bleeding grows, healthcare providers are adopting a broader range of hemostatic solutions to improve safety and reduce procedure times.

One of the most significant developments influencing this market is the growing use of combination therapies. Studies have shown that procedures combining sclerotherapy needles with ligation clips or electrosurgical probes yield higher success rates and reduce the need for repeat interventions. Because both physicians and patients seek greater procedural efficiency and lower recurrence, adoption of these combination approaches continues to increase.

While pricing pressure and procurement dynamics continue to challenge manufacturers, rising procedure volumes, broader global access, and continuous technological improvement are expected to sustain long-term growth through 2032.

Market Drivers

Combination Therapy

Combination therapies that pair sclerotherapy needles with other hemostasis devices, such as ligation clips or electrosurgical probes, have been shown to be more effective than single-device procedures. By improving hemostatic success and reducing the need for follow-up treatments, these techniques support greater physician confidence and better patient outcomes.

This approach not only increases clinical adoption but also raises unit consumption per procedure. As hospitals move toward evidence-based care models, the preference for multi-device solutions will continue to drive unit sales growth.

Ligation Clips

The ligation clip segment is showing steady growth as more physicians prefer clips over ligation bands for the management of bleeding and the closure of mucosal defects. Clips are typically used in multiples per procedure, which raises total unit volumes. In addition, clip products command a price premium compared to bands, enhancing market value growth.

Ongoing product innovation in clip design and deployment systems has further strengthened this segment. Devices that provide better precision, rotation control, and deployment reliability are improving clinical efficiency and user confidence.

Demographic Factors

Population aging remains one of the strongest macroeconomic drivers in the hemostasis device market. Older adults experience higher rates of gastrointestinal bleeding caused by chronic liver disease, variceal conditions, and comorbidities that increase bleeding risk.

At the same time, unhealthy lifestyle trends-such as poor diet, alcohol consumption, and non-steroidal anti-inflammatory drug use-are contributing to rising cases of GI bleeding even among younger populations. The combined impact of these demographic and behavioral factors is expected to keep procedural demand high and sustain market expansion through 2032.

Growing Endoscopic Capabilities

As endoscopic technologies advance, physicians can manage a wider range of bleeding conditions without surgery. Modern endoscopy systems enable precise visualization of bleeding sites, while improved electrosurgical energy control supports faster coagulation. These capabilities increase the procedural success rate and drive higher utilization of hemostasis products across hospitals and ambulatory centers.

Market Limiters

Group Purchasing Organizations (GPOs)

Group purchasing organizations represent a major procurement channel for hospital equipment but also act as a restraint on market growth. GPOs consolidate demand and negotiate bulk pricing, which restricts manufacturers' ability to maintain higher ASPs.

They also limit hospitals' access to newer or niche products by focusing on standardized purchasing contracts. Vendors that depend heavily on GPO contracts may face slower price realization and reduced flexibility to expand their product portfolios within contracted facilities.

Drug Treatment Alternatives

Pharmaceutical companies continue to develop medications designed to prevent unexpected gastrointestinal bleeding. These therapies, particularly those targeting anticoagulant reversal or ulcer protection, may reduce the incidence of bleeding that requires procedural intervention.

If these drug therapies gain widespread adoption, they could reduce procedural volumes and slow demand for mechanical and electrosurgical hemostasis devices in certain cases.

Market Cannibalization

Within the broader hemostasis market, competition among device types limits overall value growth. For instance, ligation clips-though expanding rapidly-are capturing share from electrosurgical probes, heat probes, and argon plasma coagulation probes.

While these devices can be used in combination with clips, they are most effective when paired with sclerotherapy needles. As product preferences evolve, growth in one category can come at the expense of others, resulting in internal market shifts rather than net expansion.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.

Qualitative Coverage

Growth trends, limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls, disruptive technologies, and disease overviews that influence hemostasis device demand.

Time Frame

Base year 2025, forecasts 2026 to 2032, historical data 2022 to 2024.

Data Sources

Primary interviews with endoscopists, purchasing managers, and industry executives; hospital procurement and regulatory databases; import and export data; and the iData Research internal database.

Method Note

Revenue estimates are modeled from units multiplied by ASP, validated with procedure volumes and utilization assumptions for each device type.

Markets Covered and Segmentation

• Hemostasis Device Market - Further Segmented Into:

Hemostasis Probe

Ligation Device

Sclerotherapy Needle

Hemostasis Powder

Competitive Analysis

Boston Scientific was the global leader in the hemostasis device market in 2025, maintaining strong positions across all major segments. The company's leadership in the ligation clip market was reinforced by the launch of the Resolution 360(TM) in 2016 and the upgraded Resolution 360(TM) ULTRA in 2020. Boston Scientific also markets the Gold Probe(TM) line as its flagship hemostasis probe, widely recognized for consistent performance and reliability.

Olympus Corporation ranked second in the market, supported by its broad product portfolio and long-standing expertise in gastrointestinal endoscopy. The company's leadership in the ligation device segment anchors its competitive strength. Olympus also remains the sole supplier in the heat probe market, with its HeatProbes(TM) product line used globally for endoscopic thermal coagulation.

Cook Medical held the third-largest share of the hemostasis device market. Its portfolio is led by the 6 Shooter(R) Universal Saeed(R) Multi-Ligator, which is widely used in endoscopic ligation procedures. The company also maintains a presence in ligation clips, electrosurgical probes, and sclerotherapy needles, ensuring a comprehensive offering across multiple endoscopic applications.

This competitive landscape is moderately concentrated, with the top three companies accounting for the majority of total market value. Regional competitors participate primarily in cost-sensitive markets, where pricing flexibility and local distribution relationships provide an advantage.

Technology and Practice Trends

Combination treatment protocols are becoming the standard approach for managing gastrointestinal bleeding, improving success rates and reducing rebleeding risk.

Single-use device adoption is increasing, particularly in hospitals focused on infection control and workflow efficiency.

Refinements in clip and probe design are improving procedural accuracy, rotation control, and deployment consistency.

Energy-based hemostasis technologies, including heat probes and argon plasma coagulation, remain key tools in conjunction with mechanical devices.

Training expansion and guideline alignment are enhancing physician familiarity with multi-device hemostasis procedures.

Powder-based hemostatic agents are gaining interest as adjunct tools for diffuse or difficult-to-access bleeding sites.

Together, these trends illustrate the market's shift toward integrated procedural solutions that balance safety, cost, and clinical efficiency.

Geography

This edition covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Methodology Appendix and Acronym Glossary

Why This Report

Where are the largest and fastest-growing opportunities within the global hemostasis device market

How are combination therapies and ligation clip adoption influencing market value

What factors are driving procedure volume growth in aging populations

How are drug treatments, GPO contracts, and internal device competition shaping pricing and share

Which manufacturers-Boston Scientific, Olympus, and Cook Medical-lead the market, and how are they differentiating their portfolios

What technological and procedural trends are expected to define next-generation hemostasis solutions

The Global Hemostasis Device Market Report from iData Research answers these questions with detailed procedure-based models, company share analysis, and pricing insights. Use it to plan product strategy, evaluate growth opportunities, and guide commercial and R&D decision-making.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems And Perform Secondary Research
• Step 3: Preparation For Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast And Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review And Market Release
• Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Hemostasis Device Market

• 11.1 Executive Summary
  • 11.1.1 Global Hemostasis Device Market Overview
  • 11.1.2 Competitive Analysis
  • 11.1.3 Procedure Segmentation
  • 11.1.4 Market Segmentation
  • 11.1.5 Regions Included
• 11.2 Introduction
• 11.3 Procedure Numbers
• 11.4 Market Overview
  • 11.4.1 By Segment
  • 11.4.2 By Region
• 11.5 Market Analysis And Forecast
  • 11.5.1 Hemostasis Probe Market
    • 11.5.1.1 Electrosurgical Probe Market
    • 11.5.1.2 Heat Probe Market
    • 11.5.1.3 Argon Probe Market
  • 11.5.2 Ligation Device Market
    • 11.5.2.1 Ligation Band Market
    • 11.5.2.2 Ligation Clip Market
  • 11.5.3 Sclerotherapy Needle Market
  • 11.5.4 Hemostasis Powder Market
• 11.6 Drivers And Limiters
  • 11.6.1 Market Drivers
  • 11.6.2 Market Limiters
• 11.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

• Chart 11-1: Hemostasis Device Market, Global, 2025 & 2032
• Chart 11-2: Hemostasis Device Procedures, Global, 2025
• Chart 11-3: Hemostasis Procedures by Region, Global, 2022 - 2032
• Chart 11-4: Hemostasis Device Market by Segment, Global, 2022 - 2032
• Chart 11-5: Hemostasis Device Market by Region, Global, 2022 - 2032
• Chart 11-6: Leading Competitors, Hemostasis Device Market, Global, 2025

LIST OF FIGURES

• Figure 11-1: Hemostasis Device Procedure Segmentation
• Figure 11-2: Hemostasis Device Market Segmentation
• Figure 11-3: Hemostasis Device Regions Covered, Global (1 of 2)
• Figure 11-4: Hemostasis Device Regions Covered, Global (2 of 2)
• Figure 11-5: Hemostasis Procedures by Region, Global, 2022 - 2032
• Figure 11-6: Hemostasis Procedures by Country, North America, 2022 - 2032
• Figure 11-7: Hemostasis Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
• Figure 11-8: Hemostasis Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
• Figure 11-9: Hemostasis Procedures by Country, Western Europe, 2022 - 2032
• Figure 11-10: Hemostasis Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
• Figure 11-11: Hemostasis Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
• Figure 11-12: Hemostasis Procedures by Country, Middle East, 2022 - 2032
• Figure 11-13: Hemostasis Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
• Figure 11-14: Hemostasis Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
• Figure 11-15: Hemostasis Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
• Figure 11-16: Hemostasis Procedures by Country, Africa, 2022 - 2032
• Figure 11-17: Hemostasis Device Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 11-18: Hemostasis Device Market by Region, Global, 2022 - 2032 (US$M)
• Figure 11-19: Hemostasis Probe Market by Segment, Global, 2022 - 2031 (US$M)
• Figure 11-20: Total Hemostasis Probe Market, Global, 2022 - 2032
• Figure 11-21: Units Sold by Region, Hemostasis Probe Market, Global, 2022 - 2032
• Figure 11-22: Average Selling Price by Region, Hemostasis Probe Market, Global, 2022 - 2032 (US$)
• Figure 11-23: Market Value by Region, Hemostasis Probe Market, Global, 2022 - 2032 (US$M)
• Figure 11-24: Electrosurgical Probe Market, Global, 2022 - 2032
• Figure 11-25: Units Sold by Region, Electrosurgical Probe Market, Global, 2022 - 2032
• Figure 11-26: Average Selling Price by Region, Electrosurgical Probe Market, Global, 2022 - 2032 (US$)
• Figure 11-27: Market Value by Region, Electrosurgical Probe Market, Global, 2022 - 2032 (US$M)
• Figure 11-28: Heat Probe Market, Global, 2022 - 2032
• Figure 11-29: Units Sold by Region, Heat Probe Market, Global, 2022- 2032
• Figure 11-30: Average Selling Price by Region, Heat Probe Market, Global, 2022 - 2032 (US$)
• Figure 11-31: Market Value by Region, Heat Probe Market, Global, 2022 - 2032 (US$M)
• Figure 11-32: Argon Probe Market, Global, 2022 - 2032
• Figure 11-33: Units Sold by Region, Argon Probe Market, Global, 2022 - 2032
• Figure 11-34: Average Selling Price by Region, Argon Probe Market, Global, 2022 - 2032 (US$)
• Figure 11-35: Market Value by Region, Argon Probe Market, Global, 2022 - 2032 (US$M)
• Figure 11-36: Ligation Device Market by Segment, Global, 2022 - 2032 (US$M)
• Figure 11-37: Total Ligation Device Market, Global, 2022 - 2032
• Figure 11-38: Units Sold by Region, Ligation Device Market, Global, 2022 - 2032
• Figure 11-39: Average Selling Price by Region, Ligation Device Market, Global, 2022 - 2032 (US$)
• Figure 11-40: Market Value by Region, Ligation Device Market, Global, 2022 - 2032 (US$M)
• Figure 11-41: Ligation Band Market, Global, 2022 - 2032
• Figure 11-42: Units Sold by Region, Ligation Band Market, Global, 2022 - 2032
• Figure 11-43: Average Selling Price by Region, Ligation Band Market, Global, 2022 - 2032 (US$)
• Figure 11-44: Market Value by Region, Ligation Band Market, Global, 2022 - 2032 (US$M)
• Figure 11-45: Ligation Clip Market, Global, 2022 - 2032
• Figure 11-46: Units Sold by Region, Ligation Clip Market, Global, 2022 - 2032
• Figure 11-47: Average Selling Price by Region, Ligation Clip Market, Global, 2022 - 2032 (US$)
• Figure 11-48: Market Value by Region, Ligation Clip Market, Global, 2022 - 2032 (US$M)
• Figure 11-49: Sclerotherapy Needle Market, Global, 2022 - 2032
• Figure 11-50: Units Sold by Region, Sclerotherapy Needle Market, Global, 2022 - 2032
• Figure 11-51: Average Selling Price by Region, Sclerotherapy Needle Market, Global, 2022 - 2032 (US$)
• Figure 11-52: Market Value by Region, Sclerotherapy Needle Market, Global, 2022 - 2032 (US$M)
• Figure 11-53: Hemostasis Powder Market, Global, 2022 - 2032
• Figure 11-54: Units Sold by Region, Hemostasis Powder Market, Global, 2022 - 2032
• Figure 11-55: Average Selling Price by Region, Hemostasis Powder Market, Global, 2022 - 2032 (US$)
• Figure 11-56: Market Value by Region, Hemostasis Powder Market, Global, 2022 - 2032 (US$M)
• Figure 11-57: Leading Competitors, Hemostasis Device Market, Global, 2025